4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-038659
Options or other derivatives
- Director acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Nussbaum Ran · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-06-15 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +40,000 | 40,000 | D |
Loading xslF345X03/doc4.xml…